Nicole Matsuda

Los Angeles—Greenberg Glusker is pleased to announce that it advised Zingage in connection with the company’s successful $12.5 million seed funding round.

Zingage is an AI-driven healthcare technology company dedicated to bringing high-quality care into patients’ homes. Using advanced machine learning, Zingage offers solutions to optimize scheduling, automate administration, and improve caregiver engagement and retention. With this fresh capital, Zingage aims to scale its platform, expand client acquisition, and continue innovating in the home healthcare AI space.

“This financing represents a pivotal step in Zingage’s mission to redefine home-based care,” said Eric Perlmutter-Gumbiner, corporate partner at Greenberg Glusker. “Their innovative use of AI to bring both reliability and compassion to scale exemplifies the future of the industry. We’re proud to support their vision and growth.”

The transaction was led by Eric Perlmutter-Gumbiner, with support from attorneys Peter Jackson (Intellectual Property and Technology), Nicole Matsuda (Corporate), and Emilee Wu (Corporate).

About Greenberg Glusker's Corporate Law Group

Greenberg Glusker represents clients of all sizes, types and industries in every aspect of mergers, acquisitions, reorganizations, recapitalizations, spinoffs, purchases, sales, technology transfers, and other divestitures. These range from purchases and sales of assets or stock, to complex multi-party mergers or reorganizations. Our practice experience also includes leveraged buyouts, earn-outs, split-ups and acquisitions in connection with workouts or bankruptcies, and frequently entails regulatory issues.